The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL).

F Morabito; C Stelitano; S Luminari; C Mammi; L Marcheselli; V Callea; M Gentile; G Polimeno; F Merli; S Molica

doi:10.1038/sj.bmt.1705235

The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL).

Identifier:nobleid.org/w1/20260515/D2005DFE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D2005DFE.svg?ark=w1%2F20260515%2FD2005DFE)](https://nobleid.org/work/w1/20260515/D2005DFE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL).

Identifier:nobleid.org/w1/20260515/D2005DFE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D2005DFE.svg?ark=w1%2F20260515%2FD2005DFE)](https://nobleid.org/work/w1/20260515/D2005DFE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work